FS-12W
The general trend is to move to a completely paperless manufacturing environment where all records are kept electronically. An electronic record is "any combination of text, graphics, data, audio, pictorial or other information representation in digital form that is created, modified, maintained, archived, retrieved, or distributed by a computer system" (FDA, 1997). Throughout the years, controls have been established to make paper records trustworthy and reliable. One or more handwritten signatures are used to authenticate paper records. Recently, controls have been established to help assure the same level of trustworthiness to electronic records by means of an electronic signature. An electronic signature consists of "a computer data compilation of any symbol or series of symbols executed, adopted, or authorized by an individual to be the legally binding equivalent or the individual's handwritten signature" (FDA, 1997).
One or more handwritten signatures are used to authenticate paper records. Recently, controls have been established to help assure the same level of trustworthiness to electronic records by means of an electronic signature. An electronic signature consists of "a computer data compilation of any symbol or series of symbols executed, adopted, or authorized by an individual to be the legally binding equivalent or the individual's handwritten signature" (FDA, 1997).
On March 20, 1997, the Food and Drug Administration published the Electronic Records: Electronic Signatures Rule in the Federal Register. This rule became effective on August 20, 1997. This new rule was codified as 21 CFR Part 11 and provides the criteria by which FDA will consider electronic records as equivalent to paper records and electronic signatures as equivalent to traditional handwritten signatures. It covers the creation and maintenance of electronic records and electronic signatures. This new regulation is important because it applies to food manufacturers who operate processes governed by federal regulations and want to generate, maintain, and use electronic records in association with those processes.
The electronic records and electronic signatures rule (ERESR) embodied by 21 CFR Part 11 applies to any records that are required by existing and new federal regulations. For example, 21 CFR Part 113 covers the thermal processing of low-acid foods and requires the retort operator to maintain records of specific information regarding retort process operations. If the operator uses a computer system to record these required observations electronically, then the resulting electronic records are subject to the regulations covered by the ERESR. However, the electronic records made by a production supervisor who uses a computer system to document yield and overhead expense would not be covered by the ERESR because that information is not mandated by any Federal regulation. Currently, the ERESR directly impacts food manufacturers who process low-acid shelf stable foods, seafood processors, and fruit juice processors who choose to maintain electronic records that document their compliance with Good Manufacturing Practice and HACCP regulations.
This document provides an overview of the ERESR and summarizes the controls required by FDA to comply with the ERESR.
Several guidelines were used in creating the ERESR. In general, these guidelines outline the government's expectations. Any implementation of a system used for electronic records and electronic signatures must:
The ERESR establishes specific procedures and controls. Food manufacturers who are subject to the ERESRs must be able to meet as a minimum the following FDA requirements. These items can be used as a checklist to assure compliance with the ERESR.
Systems must be validated to ensure their accuracy, reliability, consistency, and ability to discern invalid or altered records. Food processors should use "The Guide For Validation of Automated Systems in Pharmaceutical Manufacture" (GAMP, 1998) or the National Food Processors Association's Bulletin 43-L (1990) for guidance on software validation.
Systems must be able to generate accurate and complete copies of records in human readable and electronic form suitable for inspection and review.
Systems must contain an adequate means to protect records for accurate and ready retrieval throughout the record retention period. This may include systems to maintain appropriate backup records.
Systems must limit record access to authorized individuals.
Systems must use secure, computer-generated, time-stamped audit trails to independently record the date and time of operator entries and actions that create, modify, or delete electronic records. Record changes shall not obscure previously recorded information. Audit trail information must be retained throughout the record retention period and be available for FDA review and copying.
Systems must allow use of operational checks to enforce permitted sequencing of steps and events.
Systems must have some rigorously followed protocol or mechanism in place to ensure that only authorized individuals can use the system, electronically sign a record, access the operation or computer system, alter a record, or perform required operations.
Systems must include some mechanism that determines and records the validity of the source of any data entered manually.
Persons who develop, maintain, or use electronic record and signature systems must have the education, training, and experience to perform their assigned tasks.
Written policies must be established and adhered to that hold individuals accountable and responsible for actions initiated under their electronic signatures.
Systems must have adequate controls over the distribution of, access to, and use of documentation for system operation and maintenance. Revision and change control procedures to maintain an audit trail that documents the development and modification of systems documentation.
The electronic signature must contain:
A mechanism must be in place to allow electronic signatures to be linked to their respective record(s)
Sufficient controls must be in place to ensure that the electronic signature(s) and their link to the respective record cannot be removed, copied, or otherwise manipulated to falsify an electronic record.
Each electronic signature must be unique to only one individual and must not be reused by or assigned to anyone else.
The identity of an individual must be established before assigning that individual an electronic signature.
Food manufacturers who desire to use electronic signatures as legally binding equivalent of traditional handwritten signatures must certify to FDA that they intend to do so by submitting a paper letter with a traditional handwritten signature to the agency.
Persons using electronic signatures must be able to provide additional certification or testimony that a specific electronic signature is the legally binding equivalent of the signer's handwritten signature.
Systems based on biometrics must correctly identify the individuals for whom they are designed. Systems not based upon biometrics must employ at least two distinct identification components such as an identification code (IC) and password (PW). In addition, a management system must be in place to ensure that:
In taking on this new initiative in the information age, FDA has committed to educate and help industry comply with the ERESR. All documentation and materials used to develop the ERESR are available for review. Furthermore, FDA provides presentations and meetings in trade and professional groups and to individual firms. Documents covering frequently asked questions and a video are also available.
The internet site: http://www.fda.gov/cder/esig/part11.htm contains the history of the ERESR as well as the final rule as published in the federal register.
FDA 1997. 92N051 Electronic Records; Electronic Signatures.The Federal Register. Department of Health and Human Services. Food and Drug Administration 21 CFR 11 Docket Number. Vol 62 No 54. March 20, 1997.
GAMP (1998) GAMP Guide for Validation of Automated Systems in Pharmaceutical Manufacture.The Society for Pharmaceutical and Medical Device Professionals Volumes 1 and 2.
NFPA (1990) Automatic Control Guidelines for Aseptic Systems Manufacturers and Companies Using Aseptic Processing and Packaging of Preserved Foods.Bulletin 43-L National Food Processors Association, Washington, D.C.
http://www.extension.purdue.edu/extmedia/menu.htm
1-888-EXT-INFO